vs
QUALYS, INC.(QLYS)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是QUALYS, INC.的1.1倍($197.9M vs $175.3M),QUALYS, INC.净利率更高(30.3% vs 6.7%,领先23.6%),REPLIGEN CORP同比增速更快(13.6% vs 10.1%),QUALYS, INC.自由现金流更多($74.9M vs $17.6M),过去两年REPLIGEN CORP的营收复合增速更高(14.4% vs 9.6%)
Qualys是总部位于美国加利福尼亚州福斯特城的科技企业,专注于云安全、合规管理及相关服务,为客户提供覆盖云环境的安全防护与合规解决方案,助力企业应对各类网络安全风险,满足不同行业的合规运营需求。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
QLYS vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.1倍
$175.3M
营收增速更快
RGEN
高出3.5%
10.1%
净利率更高
QLYS
高出23.6%
6.7%
自由现金流更多
QLYS
多$57.4M
$17.6M
两年增速更快
RGEN
近两年复合增速
9.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $175.3M | $197.9M |
| 净利润 | $53.1M | $13.3M |
| 毛利率 | 83.4% | 52.5% |
| 营业利润率 | 33.6% | 9.0% |
| 净利率 | 30.3% | 6.7% |
| 营收同比 | 10.1% | 13.6% |
| 净利润同比 | 20.9% | 143.9% |
| 每股收益(稀释后) | $1.47 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
QLYS
RGEN
| Q4 25 | $175.3M | $197.9M | ||
| Q3 25 | $169.9M | $188.8M | ||
| Q2 25 | $164.1M | $182.4M | ||
| Q1 25 | $159.9M | $169.2M | ||
| Q4 24 | $159.2M | $174.1M | ||
| Q3 24 | $153.9M | $154.9M | ||
| Q2 24 | $148.7M | $154.1M | ||
| Q1 24 | $145.8M | $151.3M |
净利润
QLYS
RGEN
| Q4 25 | $53.1M | $13.3M | ||
| Q3 25 | $50.3M | $14.9M | ||
| Q2 25 | $47.3M | $14.9M | ||
| Q1 25 | $47.5M | $5.8M | ||
| Q4 24 | $44.0M | $-30.3M | ||
| Q3 24 | $46.2M | $-654.0K | ||
| Q2 24 | $43.8M | $3.3M | ||
| Q1 24 | $39.7M | $2.1M |
毛利率
QLYS
RGEN
| Q4 25 | 83.4% | 52.5% | ||
| Q3 25 | 83.6% | 53.2% | ||
| Q2 25 | 82.4% | 50.0% | ||
| Q1 25 | 81.9% | 53.6% | ||
| Q4 24 | 81.8% | 26.1% | ||
| Q3 24 | 81.3% | 50.0% | ||
| Q2 24 | 82.2% | 49.8% | ||
| Q1 24 | 81.3% | 49.5% |
营业利润率
QLYS
RGEN
| Q4 25 | 33.6% | 9.0% | ||
| Q3 25 | 35.3% | 8.9% | ||
| Q2 25 | 31.3% | 7.6% | ||
| Q1 25 | 32.4% | 3.9% | ||
| Q4 24 | 31.0% | -17.7% | ||
| Q3 24 | 29.2% | -5.1% | ||
| Q2 24 | 32.3% | 1.0% | ||
| Q1 24 | 30.7% | 1.3% |
净利率
QLYS
RGEN
| Q4 25 | 30.3% | 6.7% | ||
| Q3 25 | 29.6% | 7.9% | ||
| Q2 25 | 28.8% | 8.2% | ||
| Q1 25 | 29.7% | 3.4% | ||
| Q4 24 | 27.6% | -17.4% | ||
| Q3 24 | 30.0% | -0.4% | ||
| Q2 24 | 29.4% | 2.2% | ||
| Q1 24 | 27.2% | 1.4% |
每股收益(稀释后)
QLYS
RGEN
| Q4 25 | $1.47 | $0.24 | ||
| Q3 25 | $1.39 | $0.26 | ||
| Q2 25 | $1.29 | $0.26 | ||
| Q1 25 | $1.29 | $0.10 | ||
| Q4 24 | $1.19 | $-0.55 | ||
| Q3 24 | $1.24 | $-0.01 | ||
| Q2 24 | $1.17 | $0.06 | ||
| Q1 24 | $1.05 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $250.3M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $561.2M | $2.1B |
| 总资产 | $1.1B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
QLYS
RGEN
| Q4 25 | $250.3M | $767.6M | ||
| Q3 25 | $225.3M | $748.7M | ||
| Q2 25 | $194.0M | $708.9M | ||
| Q1 25 | $290.7M | $697.2M | ||
| Q4 24 | $232.2M | $757.4M | ||
| Q3 24 | $235.4M | $784.0M | ||
| Q2 24 | $281.2M | $809.1M | ||
| Q1 24 | $273.8M | $780.6M |
总债务
QLYS
RGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
QLYS
RGEN
| Q4 25 | $561.2M | $2.1B | ||
| Q3 25 | $529.4M | $2.1B | ||
| Q2 25 | $508.2M | $2.1B | ||
| Q1 25 | $498.0M | $2.0B | ||
| Q4 24 | $477.1M | $2.0B | ||
| Q3 24 | $449.6M | $2.0B | ||
| Q2 24 | $427.8M | $2.0B | ||
| Q1 24 | $404.2M | $2.0B |
总资产
QLYS
RGEN
| Q4 25 | $1.1B | $2.9B | ||
| Q3 25 | $1.0B | $2.9B | ||
| Q2 25 | $999.5M | $2.9B | ||
| Q1 25 | $996.5M | $2.9B | ||
| Q4 24 | $973.5M | $2.8B | ||
| Q3 24 | $908.3M | $2.8B | ||
| Q2 24 | $876.6M | $2.9B | ||
| Q1 24 | $861.8M | $2.8B |
负债/权益比
QLYS
RGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $75.7M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $74.9M | $17.6M |
| 自由现金流率自由现金流/营收 | 42.8% | 8.9% |
| 资本支出强度资本支出/营收 | 0.4% | 4.1% |
| 现金转化率经营现金流/净利润 | 1.42× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $304.4M | $93.9M |
8季度趋势,按日历期对齐
经营现金流
QLYS
RGEN
| Q4 25 | $75.7M | $25.7M | ||
| Q3 25 | $90.4M | $48.1M | ||
| Q2 25 | $33.8M | $28.6M | ||
| Q1 25 | $109.6M | $15.0M | ||
| Q4 24 | $47.7M | $39.2M | ||
| Q3 24 | $61.0M | $49.3M | ||
| Q2 24 | $49.8M | $42.2M | ||
| Q1 24 | $85.5M | $44.7M |
自由现金流
QLYS
RGEN
| Q4 25 | $74.9M | $17.6M | ||
| Q3 25 | $89.5M | $43.4M | ||
| Q2 25 | $32.4M | $21.5M | ||
| Q1 25 | $107.5M | $11.4M | ||
| Q4 24 | $41.9M | $33.6M | ||
| Q3 24 | $57.6M | $42.3M | ||
| Q2 24 | $48.8M | $37.4M | ||
| Q1 24 | $83.5M | $36.4M |
自由现金流率
QLYS
RGEN
| Q4 25 | 42.8% | 8.9% | ||
| Q3 25 | 52.7% | 23.0% | ||
| Q2 25 | 19.8% | 11.8% | ||
| Q1 25 | 67.3% | 6.8% | ||
| Q4 24 | 26.3% | 19.3% | ||
| Q3 24 | 37.4% | 27.3% | ||
| Q2 24 | 32.8% | 24.3% | ||
| Q1 24 | 57.2% | 24.0% |
资本支出强度
QLYS
RGEN
| Q4 25 | 0.4% | 4.1% | ||
| Q3 25 | 0.5% | 2.5% | ||
| Q2 25 | 0.8% | 3.9% | ||
| Q1 25 | 1.3% | 2.1% | ||
| Q4 24 | 3.7% | 3.2% | ||
| Q3 24 | 2.2% | 4.5% | ||
| Q2 24 | 0.7% | 3.1% | ||
| Q1 24 | 1.4% | 5.5% |
现金转化率
QLYS
RGEN
| Q4 25 | 1.42× | 1.93× | ||
| Q3 25 | 1.80× | 3.23× | ||
| Q2 25 | 0.71× | 1.92× | ||
| Q1 25 | 2.31× | 2.57× | ||
| Q4 24 | 1.09× | — | ||
| Q3 24 | 1.32× | — | ||
| Q2 24 | 1.14× | 12.70× | ||
| Q1 24 | 2.15× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
QLYS
| Sales Channel Through Intermediary | $88.6M | 51% |
| Sales Channel Directly To Consumer | $86.7M | 49% |
RGEN
暂无分部数据